Renaissance Capital logo

Centessa Pharmaceuticals Priced, Nasdaq: CNTA

Biotech holding company carved out of Medicxi.

Industry: Health Care

Latest Trade: $9.40 0.00 (0.0%)

First Day Return: +8.8%

Return from IPO: -53.0%

Industry: Health Care

Centessa Pharmaceuticals plc (Centessa) was conceived by combining the primary strengths of the asset-centric model with the benefits of diversification and scale typically attributed to traditional large R&D organizations. We were inspired by the success realized by the asset-centric model and were founded on the principle of developing asset centricity at scale. We have implemented this reimagined approach to R&D by initially combining a curated portfolio of ten wholly-owned asset-centric companies, which we refer to as the Centessa Subsidiaries, which are developing 16 high conviction programs with clear biological rationale. Each Centessa Subsidiary is led by one or more individuals whom we believe to be some of the leading subject matter experts in their respective disciplines. We empower our subsidiaries to advance their research and development plans in an independent and unbiased manner. Our programs cover a range of high-value therapeutic areas including oncology, hematology, immunology / inflammation, neuroscience, hepatology, pulmonology, nephrology, and range from discovery-stage research through late-stage clinical development. Additionally, a substantial number of our programs focus on rare disease indications with significant unmet need. We currently anticipate a total of more than a dozen clinical read-outs over the next three years, including three clinical read-outs in 2021.
more less
IPO Data
IPO File Date 04/21/2021
Offer Price $20.00
Price Range $18.00 - $20.00
Offer Shares (mm) 16.5
Deal Size ($mm) $330
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 05/27/2021
Offer Price $20.00
Price Range $18.00 - $20.00
Offer Shares (mm) 16.5
Deal Size ($mm) $330
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Morgan Stanley
Goldman Sachs
more
Company Data
Headquarters Cambridge, United Kingdom
Founded 2020
Employees 34
Website www.centessa.com

Centessa Pharmaceuticals (CNTA) Performance